BREXIN

This brand name is authorized in Albania, Brazil, Cyprus, Estonia, France, Israel, Italy, Lithuania, Singapore

Active ingredients

The drug BREXIN contains one active pharmaceutical ingredient (API):

1 Piroxicam beta-cyclodextrin UNII 13T4O6VMAM - PIROXICAM

Piroxicam is a non-steroidal anti-inflammatory agent with analgesic and antipyretic activity. It is effective regardless of the aetiology of the inflammation. Read about Piroxicam

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M01AC01	Piroxicam	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AC Oxicams
Discover more medicines within M01AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	Identifier(s): 220/370
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 517700303118410
Country: EE	Ravimiamet	Identifier(s): 1039889, 1039890
Country: FR	Base de données publique des médicaments	Identifier(s): 67229344, 68626690
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6027, 6366, 6367
Country: IT	Agenzia del Farmaco	Identifier(s): 026446056, 026446106
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004779, 1015187, 1080180, 1085611, 1085612, 1086011, 1086012
Country: SG	Health Sciences Authority	Identifier(s): 07791P